Unstable angina or non-Q wave infarction despite long-term aspirin: Response to thrombolytic therapy with implications on mechanisms
- 1 August 1990
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 120 (2) , 248-255
- https://doi.org/10.1016/0002-8703(90)90066-7
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.Circulation, 1989
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- Insights into the pathogenesis of acute ischemic syndromes.Circulation, 1988
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- Preliminary Report: Findings from the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1988
- A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris.Circulation, 1987
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- A Randomized, Controlled Trial of Aspirin in Persons Recovered From Myocardial InfarctionJAMA, 1980